N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. - Wikidata - awgldk - TriplyDB

N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress.

N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress.

http://www.wikidata.org/entity/Q44473636

about

Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells N-acetylcysteine -- passe-partout or much ado about nothing?Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats The antioxidant N-Acetylcysteine does not improve glucose tolerance or β-cell function in type 2 diabetes.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options Diabetes mellitus: channeling care through cellular discovery FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress.Reactive oxygen species enhance insulin sensitivity Review: taurine: a "very essential" amino acid.Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress.The potential usefulness of taurine on diabetes mellitus and its complications.Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity.Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.Effect of oral taurine on morbidity and mortality in elderly hip fracture patients: a randomized trial.Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function Linking mitochondrial bioenergetics to insulin resistance via redox biology Dietary Vitamin C Intake Reduces the Risk of Type 2 Diabetes in Chinese Adults: HOMA-IR and T-AOC as Potential Mediators.Protein carbonylation and adipocyte mitochondrial function.Reactive species and early manifestation of insulin resistance in type 2 diabetes.Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus Mechanistic insights into diabetes mellitus and oxidative stress Antioxidant supplemention in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance.Leptin regulation of Hsp60 impacts hypothalamic insulin signaling The antihypertensive effect of cysteine.Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue.Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.Decreased Expression of Type 5 17β-Hydroxysteroid Dehydrogenase (AKR1C3) Protein Identified in Human Diabetic Skin Tissue.Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress.L-cysteine supplementation as an adjuvant therapy for type-2 diabetes.Potential role of taurine in the prevention of diabetes and metabolic syndrome.The beneficial effects of taurine in preventing metabolic syndrome.L-cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARγ expression and decrease ROS and vascular inflammation markers in high glucose treated human U937 monocytes.

P2860

Q24655291-B441183B-8099-4EA7-8BF5-C475BCA2E5D9 Q24678741-248B33CB-EBCA-45EF-A495-3DDB916BAED1 Q26775403-D21FAA1C-AB74-4D6A-9B65-076CA7051500 Q28387506-8EE62E1C-AAFB-4391-B3AE-091876C3E24A Q28567907-234BFC49-F8A0-477C-BEBF-05815160BF90 Q28573358-F7164CED-13B1-435E-979F-70C818869A4B Q30743520-475BDBAC-E051-421D-90CC-A80C954CA24E Q33283063-C9647DDA-04EE-4993-96C4-6E2D8CCDF434 Q33625789-A02A2F02-6E6A-4CF5-9FB5-93A9DA793A19 Q33749358-A5876F26-964A-453A-BC1E-B95BEE6D8C16 Q33839935-98458ACF-5324-450F-BA50-D8674E2AA8FB Q33941647-ACFD4730-97EE-457F-939D-B1D4AA573631 Q34312980-76BED355-16D5-43B9-827E-2902E5386E3F Q34501837-F62C9ECA-B178-4DD9-A46D-09641EA02E15 Q34552287-BD626F15-DE0C-44B7-AF87-5FF2A6A5EEB1 Q34605273-701CBDFD-F4F7-49FE-99E5-19C186243829 Q34627951-5A6A4DCB-5F4A-4BF0-824E-49B5D8B865AB Q35023011-4FF718F4-48FA-4ACE-9F58-81C5A14A4F68 Q35601541-ACDE6332-0FED-4735-9164-7828DADF43EB Q35813812-E0D66034-07F3-4D23-90FB-C8AC8259E679 Q35854385-A1E2206D-6A35-423B-951C-E096BEABA1B8 Q35855378-0F26575F-4BA8-485F-970B-88E96A8DC486 Q36148747-BB1CF350-C9BA-4F31-BD59-C37949F21273 Q36294734-91389F20-0A8D-42FF-932A-4A4DA933CBC6 Q36382700-69082DE5-CE7A-4380-8CEF-539E6C6D23CD Q36431073-D8D509A3-778E-42BD-B9F3-745163237A28 Q36663152-F231EFFD-A797-427B-B26E-ED07185EEDFD Q36748171-C5618742-0DBD-47E6-A0FA-05CFFEC7543C Q37112535-9D8C732A-CA95-49B1-A272-9B6783768AF9 Q37259229-94702BC8-170A-4057-8AA9-EEBBB0992223 Q37291570-79FB6939-F3BF-4A74-B9E6-0DC120A26B8B Q37314354-0870E49D-C87A-44D5-9469-CB397047B921 Q37366549-73EC813B-CE19-43AE-835C-B841CAB7C61F Q37408370-F8BE7BE0-D7AB-4CF7-BD58-1E755A6B316B Q37698287-DC527E17-629D-4A33-AA34-E38D7097F149 Q37976675-F69EC757-6323-43BC-A381-84409C997B63 Q38025442-BF2ECE05-6ABD-4804-8C68-CAD9F7AB1B95 Q38066067-A848534E-85F8-4F8B-871E-DF520CE90145 Q38751170-65BB8139-CCCE-4445-8E86-2B7743BE503E Q39144225-C7841A94-D119-45B6-82B4-175A41CCA279

P2860

N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress.

http://www.wikidata.org/entity/Q44473636

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

N-acetylcysteine and taurine p ...... ible role of oxidative stress.

@en

N-acetylcysteine and taurine p ...... ible role of oxidative stress.

@nl

type

label

N-acetylcysteine and taurine p ...... ible role of oxidative stress.

@en

N-acetylcysteine and taurine p ...... ible role of oxidative stress.

@nl

prefLabel

N-acetylcysteine and taurine p ...... ible role of oxidative stress.

@en

N-acetylcysteine and taurine p ...... ible role of oxidative stress.

@nl

P1433

Q44473636-8C2249D3-7149-4EB7-85CE-253B57923258

P1476

Q44473636-EE511583-B45B-407E-A5D3-45236ABEBD09

P2093

Q44473636-0531D0ED-B5E1-4585-8486-9FAC9D5D4A0E

Q44473636-1B8E3D4C-5B18-4250-9EEB-088D78B9538A

Q44473636-1BAEA9D2-DC00-4A29-9FF3-7388502D306F

Q44473636-428715C3-0601-48C5-9FDC-7F8E63A47466

Q44473636-BD4F96F8-6354-4D4A-8E37-B0877B4D1E40

Q44473636-DAADC4AE-CA71-4481-9C0B-C3F4B35B10F3

Q44473636-E1323C0F-18EA-473A-983E-71523576E539

P2860

Q44473636-067FD509-69EE-4CDA-A40C-1D21E394180E

Q44473636-0F85DAAF-9BA8-44F7-9D25-F8D4AC09E640

Q44473636-163710B1-E30A-477A-9E8D-31384C000E02

Q44473636-180710B1-5D4B-4638-8DF5-664116EA7EB6

Q44473636-1877E973-2A74-4E29-815E-AF9927C31FDD

Q44473636-2656F407-FE9D-4487-88E3-0CD964B0FEA9

Q44473636-3366C171-ACF0-4F0F-8D25-5D61687CB3F4

Q44473636-34B4ADEA-0092-4B8F-8D49-9333C21A3D37

Q44473636-3514D9C1-DE9E-4155-BFC5-D3793CF10689

Q44473636-36FF255D-61F4-40CE-8984-BFBB5B7D04EF

P304

Q44473636-4E66E14E-6D05-482D-B8AA-B9D05A80D94A

P31

Q44473636-9E1D1BCA-8546-43D0-8B02-CF49815B2681

P356

Q44473636-30942ED1-9953-4288-9FF1-1B3EC4B54768

P433

Q44473636-88DA066A-5D27-4709-B3ED-6B6E36E7B2DB

P478

Q44473636-C96084FA-E93B-4E7A-90DA-9F942916C191

P50

Q44473636-F10C8A3B-1EA7-4D39-908E-DEB7E8ACAB95

P577

Q44473636-D77477CA-1B27-4142-B608-E1544AD79BDF

P5875

Q44473636-830930EF-8DF8-49DA-8C60-91E7853C37C6

P698

Q44473636-38E28113-1EB3-40B4-9182-948FBEC4CF0B

P921

Q44473636-C33899A2-17A2-4F74-9670-D8C9F89B0AE4

Q44473636-C431280F-9C98-46CE-989F-D98CB3D71777

P356

AJPENDO.00355.2002

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

N-acetylcysteine and taurine p ...... ible role of oxidative stress.

@en

P2093

C Andrew Haber

http://www.w3.org/2001/XMLSchema#string

Elena Bogdanovic

http://www.w3.org/2001/XMLSchema#string

I George Fantus

http://www.w3.org/2001/XMLSchema#string

Neehar Gupta

http://www.w3.org/2001/XMLSchema#string

Tony K T Lam

http://www.w3.org/2001/XMLSchema#string

Tracy Goh

http://www.w3.org/2001/XMLSchema#string

Zhiwen Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Biochemistry and molecular cell biology of diabetic complications

Effects of knockout of the protein kinase C beta gene on glucose transport and glucose homeostasis

Role of free radicals and catalytic metal ions in human disease: an overview

Protein oxidation in aging, disease, and oxidative stress

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

Pharmacokinetics of N-acetylcysteine in man.

P304

E744-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00355.2002

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10715192

http://www.w3.org/2001/XMLSchema#string

P698

12799318

http://www.w3.org/2001/XMLSchema#string

P921